StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)

Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –

Medpace gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Medpace

Medpace has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Medpace figures

See a number that looks wrong?